Emcure Pharmaceuticals fundamental analysis
EMCURE
1437.9
4.40 (0.31%)Last updated on 20 Feb, 2026 | 15:55 IST
BUYSELL
Free Demat with Zero AMC*
Emcure Pharmaceuticals Fundamentals
P/E Ratio
31.35
P/B Ratio
5.48
Div. Yield
0.21
Sector P/E
63.23
Sector P/B
2.76
Sec. Div. Yield
0.57
Emcure Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 31.35, compared to the sector average of 63.23. Its P/B Ratio stands at 5.48, while the sector’s is 2.76. In terms of returns, the stock offers a Dividend Yield of 0.21%, which is than the sector’s 0.57%.
Emcure Pharmaceuticals Score Card
Price
Expensive
Growth
Average
Quality
Good
Management
Good
On its scorecard, Emcure Pharmaceuticals reflects: Price – Expensive, Growth – Average, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Emcure Pharmaceuticals Associated Pages
- Emcure Pharmaceuticals Share Price
- Emcure Pharmaceuticals Share Price chart
- Emcure Pharmaceuticals Technical Analysis
- Emcure Pharmaceuticals Peer Comparison
- Emcure Pharmaceuticals Share Price History
- Emcure Pharmaceuticals Dividend
- Emcure Pharmaceuticals Board of Directors
- Emcure Pharmaceuticals Shareholding Pattern
